Maspin is a 42 kDa epithelial-specific tumor suppressor that predicts a better cancer prognosis, and is down-regulated in the progression of breast, prostate, lung, and esophageal squamous cancers [1–4]. This evidence concerns the gene SERPINB5 and cancer.